Millennium Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $56.7M | Buy |
|
|||||
|
2023
Q1 | $19.5M | Sell |
|
|||||
|
2022
Q4 | $29M | Buy |
|
|||||
|
2022
Q3 | $15.6M | Buy |
|
|||||
|
2022
Q2 | $4.63M | Sell |
|
|||||
|
2022
Q1 | $7.82M | Sell |
|
|||||
|
2021
Q4 | $16.1M | Buy |
|
|||||
|
2021
Q3 | $429K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $5.56M | Sell |
|
|||||
|
2020
Q4 | $19M | Sell |
|
|||||
|
2020
Q3 | $27.5K | Sell |
|
|||||
|
2020
Q2 | $49.6M | Buy |
|
|||||
|
2020
Q1 | $32.1M | Buy |
|
|||||
|
2019
Q4 | $43.7M | Buy |
|
|||||
|
2019
Q3 | $15.5M | Sell |
|
|||||
|
2019
Q2 | $39.9M | Sell |
|
|||||
|
2019
Q1 | $41.8M | Buy |
|
|||||
|
2018
Q4 | $7.61M | Buy |
|
|||||
|
2018
Q3 | $8.14M | Buy |
|
|||||
|
2018
Q2 | $307K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $1.16M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $727K | Sell |
|
|||||
|
2016
Q4 | $951K | Buy |
|